Corcept Therapeutics Inc (NASDAQ: CORT) open the trading on Wednesday, with great promise as it jumped 4.10% to $53.78, before settling in for the price of $51.66 at the close. Taking a more long-term approach, CORT posted a 52-week range of $20.84-$62.22.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that the giant of the Healthcare sector posted annual sales growth of 12.18% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 9.67%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 44.68%. This publicly-traded company’s shares outstanding now amounts to $104.70 million, simultaneously with a float of $90.25 million. The organization now has a market capitalization sitting at $5.63 billion. At the time of writing, stock’s 50-day Moving Average stood at $54.72, while the 200-day Moving Average is $39.08.
Corcept Therapeutics Inc (CORT) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Corcept Therapeutics Inc’s current insider ownership accounts for 13.87%, in contrast to 82.28% institutional ownership. According to the most recent insider trade that took place on Jan 10 ’25, this organization’s Director sold 2,200 shares at the rate of 50.54, making the entire transaction reach 111,188 in total value, affecting insider ownership by 0.
Corcept Therapeutics Inc (CORT) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.31 per share during the current fiscal year.
Corcept Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 44.68% and is forecasted to reach 1.91 in the upcoming year.
Corcept Therapeutics Inc (NASDAQ: CORT) Trading Performance Indicators
Let’s observe the current performance indicators for Corcept Therapeutics Inc (CORT). It’s Quick Ratio in the last reported quarter now stands at 3.64. The Stock has managed to achieve an average true range (ATR) of 2.20. Alongside those numbers, its PE Ratio stands at $42.77, and its Beta score is 0.56. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 8.96. Similarly, its price to free cash flow for trailing twelve months is now 39.51.
In the same vein, CORT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 1.26, a figure that is expected to reach 0.38 in the next quarter, and analysts are predicting that it will be 1.91 at the market close of one year from today.
Technical Analysis of Corcept Therapeutics Inc (CORT)
[Corcept Therapeutics Inc, CORT] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 79.25% While, its Average True Range was 2.12.
Raw Stochastic average of Corcept Therapeutics Inc (CORT) in the period of the previous 100 days is set at 70.78%, which indicates a major fall in contrast to 97.95% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 35.67% that was lower than 41.94% volatility it exhibited in the past 100-days period.
